Published in J Fam Pract on June 01, 2010
Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia. Asian Pac J Trop Biomed (2014) 0.80
Prevalence and Correlates of Drug-drug Interactions in the Regional Hospital of Gjilan, Kosovo. Mater Sociomed (2014) 0.75
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Cholesterol gallstone disease. Lancet (2006) 2.83
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology (2011) 2.67
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. Clin Res Hepatol Gastroenterol (2013) 1.70
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem (2007) 1.62
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem (2006) 1.60
Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother (2005) 1.41
[Patients with heart failure in the last year of their life: the primary care perspective]. G Ital Cardiol (Rome) (2014) 1.40
Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol (2010) 1.35
Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology (2008) 1.22
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr (2006) 1.17
Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol (2005) 1.16
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology (2008) 1.16
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta (2009) 1.13
Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol (2003) 1.09
The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology (2009) 1.08
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta (2007) 1.05
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol (2003) 1.03
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem (2005) 1.03
Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem (2012) 1.03
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med (2011) 1.02
Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med (2011) 1.01
Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res (2005) 1.00
Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice. Gastroenterology (2013) 1.00
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99
Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci (2008) 0.97
Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis (2011) 0.97
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One (2009) 0.96
PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. Semin Liver Dis (2013) 0.96
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem (2007) 0.94
Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets (2007) 0.94
Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta (2009) 0.93
Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study). Am J Cardiol (2012) 0.93
Steatosis in the liver. Compr Physiol (2013) 0.93
Mitochondria in chronic liver disease. Curr Drug Targets (2011) 0.93
Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93
Rendu-Osler-Weber disease: experience with 56 patients. Ann Ital Med Int (2002) 0.91
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) (2006) 0.91
Long-term functional assessment of antegrade colonic enema for combined incontinence and constipation using a modified Marsh and Kiff technique. Dis Colon Rectum (2007) 0.90
Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem (2006) 0.90
Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids (2011) 0.90
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis. Expert Opin Biol Ther (2014) 0.89
Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther (2005) 0.89
Management of liver cirrhosis between primary care and specialists. World J Gastroenterol (2011) 0.89
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis (2009) 0.89
Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol (2011) 0.88
Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des (2007) 0.87
Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Invest (2013) 0.87
Contractility in vitro and mitochondrial response in small and large rabbit bowel after anastomosis. World J Surg (2002) 0.87
A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways. J Lipids (2012) 0.87
Total thyroidectomy is improved by loupe magnification. Microsurgery (2004) 0.87
MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis (2013) 0.87
Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flow. Curr Drug Targets Immune Endocr Metabol Disord (2005) 0.86
Nuclear receptors in regenerating liver and hepatocellular carcinoma. Mol Cell Endocrinol (2012) 0.86
Lith genes and genetic analysis of cholesterol gallstone formation. Gastroenterol Clin North Am (2010) 0.86
Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection? J Lipids (2012) 0.85
Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest (2013) 0.85
New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Invest (2013) 0.85
Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care. J Cardiovasc Med (Hagerstown) (2009) 0.85
Dietary choline deprivation impairs rat brain mitochondrial function and behavioral phenotype. J Nutr (2010) 0.84
Tolerability and safety profile of risperidone in a sample of children and adolescents. Int Clin Psychopharmacol (2013) 0.84
Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology (2007) 0.84
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. Ann Hepatol (2013) 0.83
Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation. Curr Drug Targets Immune Endocr Metabol Disord (2003) 0.83
Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis. Am J Physiol Gastrointest Liver Physiol (2008) 0.83
Altered distribution of caveolin-1 in early liver steatosis. Eur J Clin Invest (2011) 0.83
Transverse leukonychia in severe hypocalcemia. Eur J Dermatol (2004) 0.83
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes. Gastroenterology (2013) 0.82
Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol (2004) 0.82
T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects. Nutrition (2010) 0.82